Advancing bio-printing of living cells for regenerative medicine

About

Opens for applications on 2027-06-03. A European Commission call for proposals. Expected Outcome: This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Developing and using new tools, technologies and digital solutions for a healthy society”. To that end, proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to most of the following expected outcomes: Biomedical scientists from academia and industry will gain access to entire bio-printing units designed to regenerate human tissue. Healthcare professionals acquire information on the safe and effective use of equipment enabling advanced therapies with bio-printed human tissue. Healthcare providers dispose of tools enabling them to treat conditions of unmet medical need. Individual patients will benefit from a personalised approach to their respective medical condition thanks to the bio-printed regenerative medicine solution. Scope: Tissue-specific functional 3D bio-printing of living cells has made significant progress as a new approach for transplantation applications in regenerative medicine. There are currently several types of bio-printing technologies under development for the r

Who can apply

Usually organisations in EU member states and associated countries, often in a consortium. Some calls are open to partners from other countries. Check the call conditions.

Best for

• Researchers
• NGOs
• Founders